Literature DB >> 9366813

Homocysteine, atherosclerosis and prevalent cardiovascular disease in the elderly: The Rotterdam Study.

M L Bots1, L J Launer, J Lindemans, A Hofman, D E Grobbee.   

Abstract

OBJECTIVES: Elevated homocysteine increases the risk of vascular disease, in particular amongst younger subjects (< 60 years). Very few studies have been performed amongst older subjects. We evaluated the relation of plasma total homocysteine (tHcy) to atherosclerosis and symptomatic cardiovascular disease amongst older men and women.
DESIGN: A cross-sectional study.
SETTING: General population.
SUBJECTS: A random sample of 630 men and women, participating in the Rotterdam Study, a prospective population-based cohort study amongst 7983 subjects aged 55 years and over residing in the Ommoord district of Rotterdam, the Netherlands. MAIN OUTCOME MEASURES: Carotid atherosclerosis (carotid plaques and common carotid intima-media thickness) assessed by ultrasonography; lower extremity (peripheral) artery atherosclerosis measured by the ratio of the ankle to arm systolic blood pressure; prevalent cardiovascular disease assessed as a history of myocardial infarction or stroke.
RESULTS: Subjects, 55-74 years of age, with elevated tHcy levels (+/- 18.6 mumol L-1) had a thicker common carotid intima-media (difference 0.037 mm; 95% CI 0.001, 0.073), a lower ankle-arm index (-0.054; -0.104, -0.004), and an increased risk of cardiovascular disease (odds ratio 3.0; 1.5, 6.1), after adjusting for sex and age. There was no appreciable association of tHcy levels to atherosclerosis and cardiovascular disease in subjects aged 75 years and older.
CONCLUSIONS: In subjects aged 55-74 years elevated tHcy is associated with an increased risk of atherosclerosis and cardiovascular disease. The lack of association in those aged > or = 75 years most probably reflect selective mortality.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9366813     DOI: 10.1046/j.1365-2796.1997.00239.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  18 in total

1.  Alzheimer's disease and the Blood-Brain Barrier: Past, Present and Future.

Authors:  Gene L Bowman; Joseph F Quinn
Journal:  Aging health       Date:  2008-02-01

Review 2.  Clinical relevance of hyperhomocysteinaemia in atherothrombotic disease.

Authors:  D A Stehouwer
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

3.  Higher homocysteine associated with thinner cortical gray matter in 803 participants from the Alzheimer's Disease Neuroimaging Initiative.

Authors:  Sarah K Madsen; Priya Rajagopalan; Shantanu H Joshi; Arthur W Toga; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2014-08-30       Impact factor: 4.673

4.  Genome-wide association study of homocysteine levels in Filipinos provides evidence for CPS1 in women and a stronger MTHFR effect in young adults.

Authors:  Leslie A Lange; Damien C Croteau-Chonka; Amanda F Marvelle; Li Qin; Kyle J Gaulton; Christopher W Kuzawa; Thomas W McDade; Yunfei Wang; Yun Li; Shawn Levy; Judith B Borja; Ethan M Lange; Linda S Adair; Karen L Mohlke
Journal:  Hum Mol Genet       Date:  2010-02-13       Impact factor: 6.150

Review 5.  Hyperhomocysteinemia and thrombosis.

Authors:  M Cattaneo
Journal:  Lipids       Date:  2001       Impact factor: 1.880

6.  Reduced risk of Alzheimer's disease with high folate intake: the Baltimore Longitudinal Study of Aging.

Authors:  María M Corrada; Claudia H Kawas; Judith Hallfrisch; Denis Muller; Ron Brookmeyer
Journal:  Alzheimers Dement       Date:  2005-07       Impact factor: 21.566

Review 7.  Homocysteine and blood pressure.

Authors:  Coen van Guldener; Prabath W B Nanayakkara; Coen D A Stehouwer
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

8.  Dietary supplement S-adenosyl-L-methionine (AdoMet) effects on plasma homocysteine levels in healthy human subjects: a double-blind, placebo-controlled, randomized clinical trial.

Authors:  Michael A Thompson; Brent A Bauer; Laura L Loehrer; Stephen S Cha; Jayawant N Mandrekar; Amit Sood; Dietlind L Wahner-Roedler
Journal:  J Altern Complement Med       Date:  2009-05       Impact factor: 2.579

9.  Methylenetetrahydrofolate reductase TT genotype as a predictor of cardiovascular risk in hypertensive adolescents.

Authors:  Hee Sun Koo; Hee Sook Lee; Young Mi Hong
Journal:  Pediatr Cardiol       Date:  2007-10-05       Impact factor: 1.655

Review 10.  Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.

Authors:  Amy R Nelson; Melanie D Sweeney; Abhay P Sagare; Berislav V Zlokovic
Journal:  Biochim Biophys Acta       Date:  2015-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.